Expert Opinion on Implementing Oral Anticoagulation Reversal Protocols in US Hospitals. [PDF]
Berger K +7 more
europepmc +1 more source
Targeted anticoagulant reversal, unintended consequences: lessons from andexanet alfa. [PDF]
Levy JH, Shaw JR.
europepmc +1 more source
Letter to the editor regarding "Recent intake of direct oral anticoagulants and acute ischemic stroke: real world data from a comprehensive stroke center" by Pommeranz et al. [PDF]
Zupan M, Kermer P, Frol S.
europepmc +1 more source
Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agents. [PDF]
El-Masri S +12 more
europepmc +1 more source
Author response to Zupan et al., Letter to the editor regarding "Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study" by Purrucker et al. [PDF]
Purrucker J +5 more
europepmc +1 more source
Spontaneous Spinal Epidural Haematoma Associated With Direct Oral Anticoagulants: A Descriptive Systematic Review. [PDF]
Ghosh S, Shine A, Sundaralingam M.
europepmc +1 more source
Critical analysis of the prescription and evaluation of monoclonal antibodies approved in Germany for the outpatient setting from 2010-2021. [PDF]
Tödter AL, Seifert R.
europepmc +1 more source
Letter to the editor regarding "Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study" by Purrucker et al. [PDF]
Zupan M, Šabovič M, Frol S.
europepmc +1 more source
Management of pericardial effusion with andexanet alfa during epicardial ventricular tachycardia ablation. [PDF]
Nakajima M +4 more
europepmc +1 more source
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase<sup>®</sup>. [PDF]
Crescioli G +10 more
europepmc +1 more source

